An update on endovascular management of acute thoracic aortic disease and future directions.
Thoracic endovascular aortic repair (TEVAR) has become an alternative treatment option for acute thoracic aortic disease. This review focuses on current endovascular treatment of acute thoracic aortic disease and future directions of TEVAR. TEVAR is a promising alternative approach to open surgery, with lower early mortality and morbidity rates, especially in high-risk cohorts. Furthermore, with accumulating experience and improving device technology and imaging modalities, TEVAR has become safer and has potential to expand treatment options to include ascending and arch pathologies.
Division of Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA.
René
R
Bombien
Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX.
George T
GT
Pisimisis
Division of Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA.
Ali
A
Khoynezhad
D000208:Acute Disease; D000784:Aortic Dissection / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D001013:Aorta, Thoracic / Q000601:surgery*; D017545:Aortic Aneurysm, Thoracic / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000401:mortality / Q000639:trends; D003952:Diagnostic Imaging; D057510:Endovascular Procedures / Q000009:adverse effects / Q000401:mortality / Q000639:trends; D005544:Forecasting; D006801:Humans; D011237:Predictive Value of Tests; D012307:Risk Factors; D016896:Treatment Outcome